Gábor Kovács
About
Gábor Kovács is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology.
According to data from OpenAlex, Gábor Kovács has authored 133 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Pulmonary and Respiratory Medicine, 61 papers in Cardiology and Cardiovascular Medicine and 18 papers in Epidemiology. Recurrent topics in Gábor Kovács's work include Pulmonary Hypertension Research and Treatments (103 papers), Cardiovascular Function and Risk Factors (43 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers). Gábor Kovács is often cited by papers focused on Pulmonary Hypertension Research and Treatments (103 papers), Cardiovascular Function and Risk Factors (43 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23 papers). Gábor Kovács collaborates with scholars based in Austria, Germany and United States. Gábor Kovács's co-authors include Horst Olschewski, Andrea Berghold, Stefan Scheidl, Andrea Olschewski, Alexander Avian, Vasile Foris, Ursula Reiter, Gert Reiter, Bradley A. Maron and Robert Maier and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.
In The Last Decade
Gábor Kovács
125 papers receiving 4.3k citations
Hit Papers
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gábor Kovács | 3.4k | 2.4k | 469 | 421 | 353 | 133 | 4.4k | |
| Kelly Chin | 4.0k 1.2× | 2.8k 1.2× | 569 1.2× | 517 1.2× | 326 0.9× | 137 | 4.9k | |
| Paul R. Forfia | 4.1k 1.2× | 4.1k 1.7× | 1.1k 2.3× | 851 2.0× | 376 1.1× | 114 | 5.9k | |
| J. Simon R. Gibbs | 4.6k 1.4× | 3.4k 1.4× | 609 1.3× | 652 1.5× | 481 1.4× | 78 | 6.0k | |
| Fumio Sakamaki | 3.0k 0.9× | 1.9k 0.8× | 505 1.1× | 466 1.1× | 162 0.5× | 87 | 4.1k | |
| Michael Halank | 4.3k 1.3× | 3.0k 1.2× | 442 0.9× | 578 1.4× | 175 0.5× | 153 | 5.0k | |
| Jean‐Luc Vachiéry | 4.9k 1.5× | 3.7k 1.5× | 637 1.4× | 1.2k 2.8× | 281 0.8× | 132 | 6.1k | |
| J. Simon R. Gibbs | 4.4k 1.3× | 3.2k 1.3× | 617 1.3× | 464 1.1× | 183 0.5× | 78 | 5.8k | |
| Alessandra Manes | 5.2k 1.5× | 3.5k 1.5× | 832 1.8× | 670 1.6× | 395 1.1× | 77 | 5.8k | |
| Fernando Torres | 3.4k 1.0× | 1.6k 0.7× | 552 1.2× | 906 2.2× | 338 1.0× | 109 | 4.4k | |
| Nobuhiro Tanabe | 2.5k 0.7× | 1.5k 0.6× | 299 0.6× | 301 0.7× | 77 0.2× | 214 | 3.6k |
Countries citing papers authored by Gábor Kovács
Since
Specialization
Citations
This map shows the geographic impact of Gábor Kovács's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gábor Kovács with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gábor Kovács more than expected).
Fields of papers citing papers by Gábor Kovács
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gábor Kovács. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gábor Kovács. The network helps show where Gábor Kovács may publish in the future.
Co-authorship network of co-authors of Gábor Kovács
This figure shows the co-authorship network connecting the top 25 collaborators of Gábor Kovács. A scholar is included among the top collaborators of Gábor Kovács based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gábor Kovács. Gábor Kovács is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jud, Philipp, Philipp Douschan, Günther Silbernagel, et al.. (2025). Endothelial function and vascular events in patients with limited cutaneous systemic sclerosis (EFVELSS): a prospective observational study. Rheumatology International. 45(7). 166–166.
2.
Bordag, Natalie, Bence Nagy, Vasile Foris, et al.. (2025). Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 211(7). 1264–1276.
3.
Zeder, Katarina, Suman Kundu, Edward D. Siew, et al.. (2025). Longitudinal Pulmonary Arterial Pressure Trajectories and Clinical Outcome in Kidney Transplantation Patients. CHEST Journal. 168(5). 1200–1214.
4.
Vitulo, Patrizio, Lucilla Piccari, Stephen J. Wort, et al.. (2024). Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension. Pulmonary Circulation. 14(4). e70005–e70005.
5.
Zeder, Katarina, Philipp Douschan, Vasile Foris, et al.. (2024). The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases. Current Opinion in Pulmonary Medicine. 30(5). 451–458.
6.
Zeder, Katarina, Edward D. Siew, Gábor Kovács, Evan L. Brittain, & Bradley A. Maron. (2024). Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes. Nature Reviews Nephrology. 20(11). 742–754.
7.
Zeder, Katarina, Evan L. Brittain, Gábor Kovács, & Bradley A. Maron. (2024). The Management of Mild Pulmonary Hypertension in Clinical Practice. Annals of the American Thoracic Society. 21(8). 1115–1123.
8.
Zeder, Katarina, Alexander Avian, Susanna Mak, et al.. (2024). Pulmonary arterial wedge pressure in healthy subjects: a meta-analysis. European Respiratory Journal. 64(2). 2400967–2400967.
9.
Zeder, Katarina, Leigh M. Marsh, Alexander Avian, et al.. (2024). Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension. The Journal of Heart and Lung Transplantation. 43(7). 1090–1101.
10.
Stoleriu, Mircea Gabriel, Michael Pienn, Peter Alter, et al.. (2024). Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET. International Journal of COPD. Volume 19. 1515–1529.
11.
Kovács, Gábor, Jude Moutchia, Katarina Zeder, et al.. (2024). Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials. American Journal of Respiratory and Critical Care Medicine. 210(6). 844–847.
12.
Pienn, Michael, Roman Johannes Gertz, Felix Gerhardt, et al.. (2023). CT-derived lung vessel morphology correlates with prognostic markers in precapillary pulmonary hypertension. The Journal of Heart and Lung Transplantation. 43(1). 54–65.
13.
Reiter, Ursula, Gábor Kovács, Clemens Reiter, et al.. (2023). Myocardial strain parameters in pulmonary hypertension are determined by changes in volumetric function rather than by hemodynamic alterations. European Journal of Radiology. 170. 111187–111187.
14.
Foris, Vasile, Christina A. Eichstaedt, Gábor Kovács, et al.. (2023). Pulmonary Vascular Remodeling May Precede Pulmonary Arterial Pressure Elevation in Pulmonary Veno-occlusive Disease- A Report of Three Cases. A1942–A1942.
15.
Kovács, Gábor, Alexander Avian, Gerhard Bachmaier, et al.. (2022). Severe Pulmonary Hypertension in COPD. CHEST Journal. 162(1). 202–212.
16.
Jandl, Katharina, Leigh M. Marsh, Ayse Ceren Mutgan, et al.. (2022). Impairment of the NKT–STAT1–CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 206(8). 981–998.
17.
Blanco, Isabel, Gábor Kovács, Zsuzsanna Helyes, et al.. (2020). Pulmonary hypertension in chronic obstructive pulmonary disease. British Journal of Pharmacology. 178(1). 132–151.
18.
Maron, Bradley A., Evan L. Brittain, Edward Hess, et al.. (2020). Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. The Lancet Respiratory Medicine. 8(9). 873–884.
19.
Biasin, Valentina, Małgorzata Wygrecka, Thomas Bärnthaler, et al.. (2018). Docking of Meprin α to Heparan Sulphate Protects the Endothelium from Inflammatory Cell Extravasation. Thrombosis and Haemostasis. 118(10). 1790–1802.
20.
Kovács, Gábor, Daniel Dumitrescu, Sebastian Greiner, et al.. (2018). Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 11–19.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kelly Chin Breakdown of academic impact, for papers by Paul R. Forfia Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Fumio Sakamaki Breakdown of academic impact, for papers by Michael Halank Breakdown of academic impact, for papers by Jean‐Luc Vachiéry Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Alessandra Manes Breakdown of academic impact, for papers by Fernando Torres Breakdown of academic impact, for papers by Nobuhiro Tanabe